Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1977 May;16(2):480–485. doi: 10.1128/iai.16.2.480-485.1977

Human nasal epithelial cell culture system: evaluation of response to human interferons.

M W Harmon, S B Greenberg, P E Johnson, R B Couch
PMCID: PMC420977  PMID: 193789

Abstract

This report describes the response of human nasal epithelial cells to exogenously applied human interferon (IF). To measure the response, a system developed to study human nasal epithelial cells in vitro was used. Nasal epithelial cells responded equally to both leukocyte and fibroblast IF, with development of resistance to virus replication that was time and dose dependent. Cells required contact with 1,000 U of IF (400 69/19 reference units) for 4 h to produce consistently a significant reduction in virus yield. This in vitro cell cultured system may be useful in predicting the in vivo response of human IF in respiratory viral infections.

Full text

PDF
480

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alford B. R., Douglas R. G., Jr, Couch R. B. Atraumatic biopsy of nasal mucosa. Arch Otolaryngol. 1969 Aug;90(2):180–184. doi: 10.1001/archotol.1969.00770030182018. [DOI] [PubMed] [Google Scholar]
  2. Aoki F. Y., Crowley J. C. Distribution and removal of human serum albumin-technetium 99m instilled intranasally. Br J Clin Pharmacol. 1976 Oct;3(5):869–878. doi: 10.1111/j.1365-2125.1976.tb00640.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Came P. E., Schafer T. W., Silver G. H. Sensitivity of rhinoviruses to human leukocyte and fibroblast interferons. J Infect Dis. 1976 Jun;133 (Suppl):A136–A139. doi: 10.1093/infdis/133.supplement_2.a136. [DOI] [PubMed] [Google Scholar]
  4. Cantell K., Hirvonen S., Mogensen K. E., Pyhälä L. Human leukocyte interferon: production, purification, stability, and animal experiments. In Vitro Monogr. 1974;(3):35–38. [PubMed] [Google Scholar]
  5. Cate T. R., Douglas R. G., Jr, Couch R. B. Interferon and resistance to upper respiratory virus illness. Proc Soc Exp Biol Med. 1969 Jun;131(2):631–636. doi: 10.3181/00379727-131-33941. [DOI] [PubMed] [Google Scholar]
  6. DULBECCO R., VOGT M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954 Feb;99(2):167–182. doi: 10.1084/jem.99.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Douglas R. G., Jr, Betts R. F. Effect of induced interferon in experimental rhinovirus infections in volunteers. Infect Immun. 1974 Mar;9(3):506–510. doi: 10.1128/iai.9.3.506-510.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harmon M. W., Greenberg S. B., Couch R. B. Effect of human nasal secretions on the antiviral activity of human fibroblast and leukocyte interferon. Proc Soc Exp Biol Med. 1976 Sep;152(4):598–602. doi: 10.3181/00379727-152-39448. [DOI] [PubMed] [Google Scholar]
  9. Havell E. A., Berman B., Ogburn C. A., Berg K., Paucker K., Vilcek J. Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2185–2187. doi: 10.1073/pnas.72.6.2185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Havell E. A., Vilcek J. Production of high-titered interferon in cultures of human diploid cells. Antimicrob Agents Chemother. 1972 Dec;2(6):476–484. doi: 10.1128/aac.2.6.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hill D. A., Baron S., Perkins J. C., Worthington M., Van Kirk J. E., Mills J., Kapikian A. Z., Chanock R. M. Evaluation of an interferon inducer in viral respiratory disease. JAMA. 1972 Feb 28;219(9):1179–1184. [PubMed] [Google Scholar]
  12. Ho M., Armstrong J. A. Interferon. Annu Rev Microbiol. 1975;29:131–161. doi: 10.1146/annurev.mi.29.100175.001023. [DOI] [PubMed] [Google Scholar]
  13. Johnson P. E., Greenberg S. B., Harmon M. W., Alford B. R., Couch R. B. Recovery of applied human leukocyte interferon from the nasal mucosa of chimpanzees and humans. J Clin Microbiol. 1976 Jul;4(1):106–107. doi: 10.1128/jcm.4.1.106-107.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Merigan T. C., Reed S. E., Hall T. S., Tyrrell D. A. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973 Mar 17;1(7803):563–567. doi: 10.1016/s0140-6736(73)90714-9. [DOI] [PubMed] [Google Scholar]
  15. Murphy B. R., Baron S., Chalhub E. G., Uhlendorf C. P., Chanock R. M. Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus. J Infect Dis. 1973 Oct;128(4):488–493. doi: 10.1093/infdis/128.4.488. [DOI] [PubMed] [Google Scholar]
  16. Panusarn C., Stanley E. D., Dirda V., Rubenis M., Jackson G. G. Prevention of illness from rhinovirus infection by a topical interferon inducer. N Engl J Med. 1974 Jun 11;291(2):57–61. doi: 10.1056/NEJM197407112910201. [DOI] [PubMed] [Google Scholar]
  17. Schiff L. J., Shefner A. M. Influence of oxygen and culture media on maintenance of whole hamster trachea organ cultures and replication of Sendai virus. J Clin Microbiol. 1975 Jan;1(1):44–49. doi: 10.1128/jcm.1.1.44-49.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stampfer M., Baltimore D., Huang A. S. Absence of interference during high-multiplicity infection by clonally purified vesicular stomatitis virus. J Virol. 1971 Mar;7(3):409–411. doi: 10.1128/jvi.7.3.409-411.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Stewart II W. E., De Somer P., Edy V. G., Paucker K., Berg K., Ogburn C. A. Distinct molecular species of human interferons: requirements for stabilzation and reactivation of human leukocyte and fibroblast interferons. J Gen Virol. 1975 Mar;26(3):327–331. doi: 10.1099/0022-1317-26-3-327. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES